Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Spain

 

Centene to acquire control of Ribera Salud

Centene, the massive American third-party administrator, is increasing its 50% stake in Spanish health management group Ribera Salud to 90%. The deal, which is going through regulatory approval, values Ribera at €125-140m and could be a signal of more acquisitions outside the US as the health reform which helped it grow looks increasingly under attack by President Trump.

DomusVi: Insurers need to see the value in homecare

Europe's third-largest nursing home operator by revenue, DomusVi, claims its homecare business saves 35% on hospitalisation costs for private Spanish insurers. So why do they still need convincing to pay for homecare services? We speak to the director of DomusVi Healthcare, David Fernández.

How to make telemonitoring succeed

How do you make a success of telemonitoring for patients, professionals and health systems alike? This was the key question for the expert panel at HBI2019's policy summit which included Dr Daan Dohmen, CEO of Dutch telemonitoring company FocusCura, and managing director of social welfare for the Province of Barcelona Josep Muñoz Luque.

DocPlanner flying towards Unicorn status

DocPlanner, the online booking and rating platform rival to Doctolib, has just closed a Series E funding round for €80m, but the company says it has "some way to go" to unicorn status. 

Is Spanish mental health hotting up?

Recent activity in Spanish psychiatry and mental health suggests growth on this market is picking up speed. Who are the emerging consolidators? We speak to market experts following this space.

Wafer-thin health care service profits at Bupa

Why did Bupa, the international health insurer which is also one of the largest health care service players outside of the USA, announce its 2018 results so quietly that HBI isn't aware of any UK daily reporting them this year? The figures show that Bupa's £3.37bn of revenue from nursing homes, hospitals, dentistry and primary care across a dozen countries, barely made money. Could this be down to its interesting governance structure?

Find Us